RecruitingNot ApplicableNCT06724861

Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy

Sensory Rehabilitation in CIPN

Sponsor

Assaf-Harofeh Medical Center

Enrollment

27 participants

Start Date

Apr 8, 2025

Study Type

INTERVENTIONAL

Conditions

Chemotherapy Induced Peripheral Neuropathy CIPN - Chemotherapy-Induced Peripheral Neuropathy Age Over 18

Summary

This study is a cross-over RCT evaluating the effectiveness of 3 sessions a week apart of explicit sensory retraining to the lower extremities in individuals with CIPN versus usual care. The primary outcome measures are TNAS for subjective symptoms, VAS for pain and TUG for mobility. Additional outcome measures are FABS for balance, sensory assessments - monofilaments for touch threshold, LEPT for proprioception, a home exercise log and a satisfaction questionnaire.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Explicit Sensory Retraining for the lower extremities and no treatment for people with age over 18, cipn - chemotherapy-induced peripheral neuropathy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExplicit Sensory Retraining for the lower extremities

Sensory retraining of detection, discrimination, quantification of a stimuli and recognition of stimuli and objects with the leg and mainly with the foot. Top-down awareness of bottom-up sensory experience in the treatment session and in everyday life.

OTHERno treatment

Usual care